Monoclonal gammopathy of undetermined significance

Last reviewed: 3 Sep 2022
Last updated: 28 Mar 2019

Summary

Definition

History and exam

Key diagnostic factors

  • at-risk demographic (male, age >50 years, African ancestry)
  • clinically asymptomatic
  • positive family history
  • history of radiation exposure
  • history of pesticide exposure
More key diagnostic factors

Other diagnostic factors

  • history of immunosuppression or infections
  • presence of peripheral neuropathy
Other diagnostic factors

Risk factors

  • male sex
  • age >50 years
  • African ancestry
  • family history of MGUS or multiple myeloma
  • immune-mediated conditions
  • radiation exposure
  • pesticide exposure
More risk factors

Diagnostic investigations

1st investigations to order

  • electrophoresis with immunofixation and measurement of serum immunoglobulins
  • CBC with differential
  • serum calcium
  • serum creatinine
  • urinalysis and 24-hour urine collection with electrophoresis and immunofixation
  • serum free light chains assay
  • metastatic bone survey (conventional x-ray or whole body low-dose CT scan)
More 1st investigations to order

Investigations to consider

  • bone marrow aspiration and/or biopsy
  • bone mineral density scan
  • MRI scan
  • PET scan
More investigations to consider

Treatment algorithm

ONGOING

confirmed MGUS

Contributors

Authors

Shaji Kumar, MD

Professor of Medicine

Division of Hematology

Mayo Clinic

Rochester

MN

Disclosures

SK has served as a consultant for Janssen, Abbvie, Amgen, Merck, Celgene, Takeda, and Skyline.

Acknowledgements

Professor Shaji Kumar would like to gratefully acknowledge Dr Ola Landgren, a previous contributor to this topic. OL is an author of several references cited in this topic.

Peer reviewers

Daniel Catovsky, MD

Consultant Haemato-Oncologist

Section of Haemato-Oncology

Brookes Lawley Institute of Cancer

Sutton

UK

Disclosures

DC declares that he has no competing interests.

  • Monoclonal gammopathy of undetermined significance images
  • Differentials

    • Multiple myeloma or smoldering myeloma
    • Amyloidosis
    • Waldenström macroglobulinemia
    More Differentials
  • Guidelines

    • The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network
    • The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders
    More Guidelines
  • Patient leaflets

    Monoclonal gammopathy of undetermined significance

    More Patient leaflets
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer